We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetic Link Found for Physical and Psychological Disorders

By LabMedica International staff writers
Posted on 22 Mar 2018
Results of a series of genome-wide association studies have indicated that insomnia is at least partially hereditary and that it is linked to physical and psychological disorders such as depression and type II diabetes.

Based on earlier genomic studies that had demonstrated the heritability of insomnia, investigators at the University of California, San Diego (USA) conducted genome-wide association studies (GWAS) on DNA samples obtained from more than 33,000 soldiers participating in the Army Study to Assess Risk and Resilience in Servicemembers (STARRS). More...
For this study, GWAS were carried out separately for each ancestral group (EUR, AFR, LAT).

Results published in the March 8, 2018, online edition of the journal Molecular Psychiatry revealed that heritability (SNP-based) for lifetime insomnia disorder was significant. Genetic contributions to insomnia disorder in STARRS were significantly positively correlated with major depressive disorder and type II diabetes, and negatively with morningness chronotype and subjective wellbeing.

In addition, the study identified a genome-wide significant locus on chromosome seven and a genome-wide significant gene-based association in the EUR group on chromosome nine.

"Several of these variants rest comfortably among locations and pathways already known to be related to sleep and circadian rhythms," said senior author Dr. Murray Stein, professor of psychiatry, family medicine, and public health at the University of California, San Diego. "Such insomnia associated loci may contribute to the genetic risk underlying a range of health conditions including psychiatric disorders and metabolic disease. The genetic correlation between insomnia disorder and other psychiatric disorders, such as major depression, and physical disorders such as type II diabetes suggests a shared genetic diathesis for these commonly co-occurring phenotypes. A better understanding of the molecular bases for insomnia will be critical for the development of new treatments."

Related Links:
University of California, San Diego


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.